Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

AJOVY® Formally Included in China’s National Reimbursement Drug List 2026

SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- On November 14, NeuroGen announced that it's in-licensed innovative drug AJOVY® (fremanezumab injection) from TEVA has been successfully listed on China's National Reimbursement Drug List (NRDL) following the latest round of national price negotiations1. Marking a breakthrough as the first CGRP inhibitor covered by national...

diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy. SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- The diaTribe Foundation announces...

NVISAGE Technologies to Present Complete Golf Launch Monitor Lineup at PGA Show 2026

CHICAGO,...

Delta Intelligent Building Technologies Receives the 2025 Global Integrated Smart Buildings Solutions Competitive Strategy Leadership Recognition

Frost & Sullivan honors the company for its leadership in technology integration, collaboration, and innovation across the smart buildings ecosystem SAN ANTONIO, Jan....

Field Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

CARDIFF-BY-THE-SEA,...

Basecamp Research launches world-first AI models for programmable gene insertion

The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and...

Relativity Launches aiR for Case Strategy, Bringing Generative AI to Case Intelligence

News Summary: Relativity's generative AI case intelligence solution, aiR for Case Strategy, launched for general availability today. aiR for...
1...1,5391,5401,541...4,531Page 1,540 of 4,531